Holen Sie sich die Stockscreener-App
2.99
7.17%
0.20
Handel nachbörslich:
2.96
-0.03
-1.00%
Schlusskurs vom Vortag:
$2.79
Offen:
$2.77
24-Stunden-Volumen:
26,067
Relative Volume:
0.36
Marktkapitalisierung:
$4.61M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-1.0873
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
+2.75%
1M Leistung:
-24.87%
6M Leistung:
-28.72%
1J Leistung:
-14.57%
1-Tages-Spanne:
$2.712
$2.99
1-Wochen-Bereich:
$2.625
$3.04
52-Wochen-Spanne:
$2.20
$5.2683
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Firmenname
Xenetic Biosciences Inc
Sektor
Branche
Telefon
781-778-7720
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Vergleichen Sie XBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.99 | 4.30M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-08 | Eingeleitet | Maxim Group | Buy |
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Xenetic Biosciences: Operational Efficiency and Clinical Catalysts in DNase-Based Oncology - AInvest
Quantitative breakdown of Xenetic Biosciences Inc. recent moveWeekly Investment Recap & Risk Controlled Daily Trade Plans - Newser
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results - The Joplin Globe
Xenetic Advances Novel DNase-CAR T Cancer Therapy Program with Scripps, Reports $4.8M Cash Position - Stock Titan
Xenetic Biosciences Inc. stock volume spike explained2025 Momentum Check & Smart Money Movement Tracker - Newser
H.C. Wainwright Maintains Hold Rating on Xenetic Biosciences (XBIO) - AInvest
Technical analysis overview for Xenetic Biosciences Inc. stockMarket Trend Review & Free Technical Confirmation Trade Alerts - Newser
Xenetic Biosciences: Q2 Earnings Snapshot - New Haven Register
Is Xenetic Biosciences Inc. stock entering bullish territory2025 Market Sentiment & AI Driven Stock Movement Reports - Newser
Xenetic Biosciences Inc. stock retracement – recovery analysisTrade Ideas & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-08-13 01:08:00 - Newser
Xenetic Biosciences Reports Improved Financial Performance - TipRanks
Xenetic Biosciences 2025 Q2 Earnings Improved Losses but Revenue Declines - AInvest
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates - sharewise.com
Xenetic Biosciences: Can DNase-Based Therapies Justify the Valuation Amid Financial Losses? - AInvest
Xenetic Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Xenetic Biosciences, Inc. SEC 10-Q Report - TradingView
Does Xenetic Biosciences Inc. meet Warren Buffett’s criteriaHigh Return in Low Timeframe - newsyoung.net
Should you hold or exit Xenetic Biosciences Inc. nowEquity Portfolio Outlook and Performance Summary - Newser
Why Xenetic Biosciences Inc. stock attracts strong analyst attentionFree Sector Rotation Based Trading Opportunities - Newser
Has Xenetic Biosciences Inc. found a price floorFree Buy Alerts With Low Risk Confirmation - Newser
Xenetic Biosciences Inc. stock trend forecastFree Price Action Based Buy Opportunity List - Newser
Xenetic Biosciences (XBIO) to Release Earnings on Tuesday - Defense World
Xenetic Biosciences XBIO 2025Q2 Earnings Preview Upside Potential Driven by Strategic Partnerships - AInvest
Top chart patterns to watch in Xenetic Biosciences Inc.Buy/Sell Zone Confirmation Technical Analysis - Newser
Using flow based indicators on Xenetic Biosciences Inc.Weekly Stock Market Strategy Summary - Newser
Will Xenetic Biosciences Inc. benefit from macro trendsEarly Buy Opportunity with Chart Triggers - Newser
Xenetic Biosciences Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Is Xenetic Biosciences Inc. meeting your algorithmic filter criteriaDaily Pick Forecast with Entry Zones - Newser
What makes Xenetic Biosciences Inc. stock price move sharplyEarly Entry Planner for Swing Candidates - Newser
Xenetic Biosciences Inc. stock outlook for YEARDaily Market Momentum Summary and Strategy - Newser
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Short Interest Up 69.9% in July - Defense World
How Xenetic Biosciences Inc. stock performs during market volatilityFree Entry Plan for Oversold Reversal Stocks - Newser
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma - The Columbus Dispatch
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - Lancaster Eagle-Gazette
What machine learning models say about Xenetic Biosciences Inc.AI Volatility Forecast and Risk Monitor - Newser
Buy Signal for Xenetic Biosciences Inc. Stock Key Technical Indicators to WatchAI Model Forecasting Reversal and Breakout Zones - Newser
What drives Xenetic Biosciences Inc. stock priceReal-time trading signals for maximum returns - Jammu Links News
When is Xenetic Biosciences Inc. stock expected to show significant growthMaximize returns with expert trading insights - Jammu Links News
What are the technical indicators suggesting about Xenetic Biosciences Inc.Get alerts on top growth stocks daily - Jammu Links News
Should I hold or sell Xenetic Biosciences Inc. stock in 2025Free Technical Analysis Support - Jammu Links News
Is Xenetic Biosciences Inc. a good long term investmentTriple returns potential - Jammu Links News
What catalysts could drive Xenetic Biosciences Inc. stock higher in 2025Stay ahead with daily expert stock picks - Jammu Links News
Is Xenetic Biosciences Inc. stock overvalued or undervaluedAchieve breakthrough profits with expert advice - Jammu Links News
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):